ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,036 | -18.8% | 68,080 | 0.0% | 0.16% | -18.3% |
| Q2 2023 | $456,817 | -24.0% | 68,080 | 0.0% | 0.19% | -28.5% |
| Q1 2023 | $601,146 | +15.6% | 68,080 | 0.0% | 0.27% | +3.9% |
| Q4 2022 | $520,131 | +7.3% | 68,080 | 0.0% | 0.26% | +4.5% |
| Q3 2022 | $484,730 | -12.0% | 68,080 | 0.0% | 0.25% | -10.9% |
| Q2 2022 | $550,767 | -41.7% | 68,080 | 0.0% | 0.28% | -45.2% |
| Q1 2022 | $944,950 | -50.5% | 68,080 | 0.0% | 0.50% | -69.3% |
| Q4 2021 | $1,910,325 | -57.8% | 68,080 | -48.9% | 1.64% | -63.4% |
| Q3 2021 | $4,531,887 | -16.8% | 133,330 | 0.0% | 4.48% | -21.8% |
| Q2 2021 | $5,447,864 | – | 133,330 | – | 5.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |